Clozapine, HIV and neutropenia: a case report | Zendy

Eromona Whiskey | Zendy; David O’Flynn | Zendy; David Taylor | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clozapine, HIV and neutropenia: a case report

Author(s) -

Eromona Whiskey,

David O’Flynn,

David Taylor

Publication year - 2018

Publication title -

therapeutic advances in psychopharmacology

Language(s) - English

Resource type - Journals

eISSN - 2045-1261

pISSN - 2045-1253

DOI - 10.1177/2045125318804499

Subject(s) - clozapine , dyscrasia , medicine , neutropenia , human immunodeficiency virus (hiv) , drug , intensive care medicine , antipsychotic , ethnic group , antipsychotic drug , psychiatry , schizophrenia (object oriented programming) , immunology , chemotherapy , plasma cell , sociology , anthropology , multiple myeloma

There is paucity of information on the use of clozapine in patients with HIV. Ethnicity, co-prescribed medications and possible drug-drug interactions are important considerations in evaluating risk of blood dyscrasias during clozapine treatment. Individuals with HIV should not be denied access to the most effective antipsychotic, but a multidisciplinary approach is essential for optimal outcome in such complex patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research